THE COST-EFFECTIVENESS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) FOR TREATING ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA IN THE UNITED KINGDOM

被引：0
|
作者：
Walton, M. [1 ]
Claxton, L. [1 ]
Sharif-Hurst, S. [1 ]
Wade, R. [1 ]
Eastwood, A. [1 ]
Hodgson, R. [1 ]
机构：
[1] Univ York, York, Yor, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MT4
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [21] Survival and Response after Selective Internal Radiation Therapy (SIRT) for advanced Hepatocellular Carcinoma with and without portal vein thrombosis
    Hamami, M. E.
    Poeppel, T.
    Mueller, S.
    Ertle, J.
    Antoch, G.
    Bockisch, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S279 - S279
  • [22] Survival and response after selective internal radiation therapy (SIRT) for advanced hepatocellular carcinoma with and without portal vein thrombosis
    Hamami, Monia
    Antoch, Gerald
    Mueller, Stefan
    Ertle, Judith
    Boy, Christian
    Poeppel, Thorsten
    Hilgard, Philip
    Bockisch, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [23] ASSESSING THE COST-EFFECTIVENESS OF LENVATINIB AS A FIRST-LINE THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN CANADA
    Kim, John J.
    McFarlane, Thomas
    Tully, Stephen
    Wong, William W. L.
    MEDICAL DECISION MAKING, 2020, 40 (01) : E3 - E4
  • [24] Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom
    Garay, Osvaldo Ulises
    Ambuhl, Louisa Elena
    Bird, Thomas G.
    Barnes, Eleanor
    Irving, William L.
    Walkley, Ryan
    Rowe, Ian A.
    VALUE IN HEALTH, 2024, 27 (12) : 1698 - 1709
  • [25] Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost-effectiveness analysis
    Cai, Hongfu
    Zhang, Longfeng
    Li, Na
    Zheng, Bin
    Liu, Maobai
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (08) : 553 - 562
  • [26] Downstaging locally advanced hepatocellular carcinoma with selective internal radiation therapy.
    Hoang, Marjorie
    Chow, Pierce K. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 536 - 536
  • [27] Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma
    Marqueen, Kathryn E.
    Kim, Edward
    Ang, Celina
    Mazumdar, Madhu
    Buckstein, Michael
    Ferket, Bart S.
    JCO ONCOLOGY PRACTICE, 2021, 17 (02) : E266 - E277
  • [28] Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies
    Cucchetti, Alessandro
    Cappelli, Alberta
    Ercolani, Giorgio
    Mosconi, Cristina
    Cescon, Matteo
    Golfieri, Rita
    Pinna, Antonio Daniele
    LIVER CANCER, 2016, 5 (04) : 303 - 311
  • [29] A SELECTIVE INTERNAL RADIATION THERAPY (SIRT) FOR HEPATOCELLULAR CARCINOMA AUDIT - INFORMING UK MDT PRACTICE
    Reeves, Helen
    Reicher, John
    Priona, Georgia
    Manas, Derek
    Littler, Peter
    GUT, 2022, 71 : A10 - A11
  • [30] Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma
    Bujold, A.
    Dawson, L. A.
    CANCER RADIOTHERAPIE, 2011, 15 (01): : 54 - 63
12345